Enhanced Weight Loss in Postmenopausal Women: The Role of Hormone Therapy and Semaglutide
A recent study has highlighted a significant finding in the field of weight loss treatments for postmenopausal women. According to the research, postmenopausal women undergoing hormone therapy exhibited significantly greater weight loss when treated with the glucagon-like peptide 1 (GLP-1) receptor agonist drug Semaglutide, compared to those not receiving hormone therapy. This preliminary yet notable…